HYPERBILIRUBINEMIA, NEONATAL INDIRECT

Clinical trials for HYPERBILIRUBINEMIA, NEONATAL INDIRECT explained in plain language.

Never miss a new study

Get alerted when new HYPERBILIRUBINEMIA, NEONATAL INDIRECT trials appear

Sign up with your email to follow new studies for HYPERBILIRUBINEMIA, NEONATAL INDIRECT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a common liver pill speed up jaundice recovery in newborns?

Symptom relief Recruiting now

This study tests whether adding a medicine called ursodeoxycholic acid (UDCA) to standard light therapy helps newborns with jaundice get better faster. About 70 full-term or near-full-term babies will be randomly assigned to receive either light therapy alone or light therapy plu…

Matched conditions: HYPERBILIRUBINEMIA, NEONATAL INDIRECT

Phase: NA • Sponsor: Tishreen University Hospital • Aim: Symptom relief

Last updated May 14, 2026 12:02 UTC

HYPERBILIRUBINEMIA, NEONATAL INDIRECT

Get alerted when new HYPERBILIRUBINEMIA, NEONATAL INDIRECT trials appear

Could a common liver pill speed up jaundice recovery in newborns?